טוען...
Revisiting Serotonin Reuptake Inhibitors and the Therapeutic Potential of “Uptake-2” in Psychiatric Disorders
[Image: see text] Depression is among the most common psychiatric disorders, and in many patients a disorder for which available medications provide suboptimal or no symptom relief. The most commonly prescribed class of antidepressants, the selective serotonin reuptake inhibitors (SSRIs), are though...
שמור ב:
| Main Authors: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Chemical
Society
2013
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3547475/ https://ncbi.nlm.nih.gov/pubmed/23336039 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/cn3001872 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|